Cargando…

Three-year follow-up of Interleukin 6 and C-reactive protein in chronic obstructive pulmonary disease

BACKGROUND: Past studies have shown that mean values of Interleukin-6 (IL-6) and C-reactive protein (CRP) do not change significantly in COPD patients over a one-year period. However, longer period follow-up studies are still lacking. Thus, the aim of this study is to evaluate plasma CRP and IL-6 co...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferrari, Renata, Tanni, Suzana E, Caram, Laura MO, Corrêa, Corina, Corrêa, Camila R, Godoy, Irma
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620569/ https://www.ncbi.nlm.nih.gov/pubmed/23425215 http://dx.doi.org/10.1186/1465-9921-14-24

Ejemplares similares

Predictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary disease
por: Ferrari, Renata, et al.
Publicado: (2011)

Nine-Year Follow-Up of Interleukin 6 in Chronic Obstructive Pulmonary Disease – Complementary Results from Previous Studies
por: Prudente, Robson, et al.
Publicado: (2021)

Association between left ventricular diastolic dysfunction and severity of chronic obstructive pulmonary disease
por: de Oliveira Caram, Laura Miranda, et al.
Publicado: (2013)

Relation between systemic inflammatory markers, peripheral muscle mass, and strength in limb muscles in stable COPD patients
por: Ferrari, Renata, et al.
Publicado: (2015)

Serum Vitamin A and Inflammatory Markers in Individuals with and without Chronic Obstructive Pulmonary Disease
por: Caram, L. M. O., et al.
Publicado: (2015)

Smoking status and tumor necrosis factor-alpha mediated systemic inflammation in COPD patients
por: Tanni, Suzana E, et al.
Publicado: (2010)

Assessment of Aerobic Exercise Adverse Effects during COPD Exacerbation Hospitalization
por: Knaut, Caroline, et al.
Publicado: (2017)

DNA damage and antioxidant capacity in COPD patients with and without lung cancer
por: dos Santos, Camila Freitas, et al.
Publicado: (2022)

Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year
por: Mesquita, Carolina Bonfanti, et al.
Publicado: (2018)

Smoking and Early COPD as Independent Predictors of Body Composition, Exercise Capacity, and Health Status
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2016)

Increased production of hydrogen peroxide by peripheral blood monocytes associated with smoking exposure intensity in smokers
por: Tanni, Suzana E, et al.
Publicado: (2012)

Tumor necrosis factor receptor 2 as a possible marker of COPD in smokers and ex-smokers
por: Caram, Laura Miranda de Oliveira, et al.
Publicado: (2017)

Brief Intervention for Smoking Cessation During Pregnancy
por: Bertani, Andre, et al.
Publicado: (2021)

The importance of knowing the home conditions of patients receiving long-term oxygen therapy
por: Godoy, Ilda, et al.
Publicado: (2012)

Predictors of mortality in patients with COPD after 9 years
por: Prudente, Robson, et al.
Publicado: (2018)

Dual and Poly Use of Tobacco Products in a Sample of Pregnant Smokers: A Cross-sectional Study
por: Bertani, André Luís, et al.
Publicado: (2023)

Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients
por: Prudente, Robson, et al.
Publicado: (2021)

Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification
por: Baldi, Bruno Guedes, et al.
Publicado: (2021)

Preventing smoking during pregnancy: the importance of maternal knowledge of the health hazards and of the treatment options available
por: Bertani, André Luís, et al.
Publicado: (2015)

Evaluation of smoking cessation treatment initiated during hospitalization in patients with heart disease or respiratory disease
por: Garcia, Thaís, et al.
Publicado: (2018)

Evaluation of Inflammatory Markers in Patients Undergoing a Short-Term Aerobic Exercise Program while Hospitalized due to Acute Exacerbation of COPD
por: Knaut, Caroline, et al.
Publicado: (2020)

Interleukin-6 and C-Reactive Protein Are Overexpressed in the Liver of Perinatal Deaths Diagnosed with Fetal Inflammatory Response Syndrome
por: Pereira, Lívia Helena M., et al.
Publicado: (2014)

Different Clusters in Patients with Chronic Obstructive Pulmonary Disease (COPD): A Two-Center Study in Brazil
por: Zucchi, José William, et al.
Publicado: (2020)

Reference values for the incremental shuttle walk test in healthy subjects: from the walk distance to physiological responses ,
por: Dourado, Victor Zuniga, et al.
Publicado: (2013)

Brazilian pulmonology guidelines on Delphi panel for post-coronavirus disease 2019
por: Tanni, Suzana Erico, et al.
Publicado: (2023)

The Association of Systemic Interleukin 6 and Interleukin 10 Levels with Sarcopenia in Elderly Patients with Chronic Obstructive Pulmonary Disease
por: Lin, Baiyang, et al.
Publicado: (2021)

Risk Perceptions and Behavior Among Hospitalized Patients With Smoking-Related Diseases
por: Tanni, Suzana E., et al.
Publicado: (2009)

Interleukin-6 and airflow limitation in chemical warfare patients with chronic obstructive pulmonary disease
por: Attaran, Davood, et al.
Publicado: (2010)

Trial of Atorvastatin on Serum Interleukin-6, Total Antioxidant Capacity, C-Reactive Protein, and Alpha-1 Antitrypsin in Patients with Chronic Obstructive Pulmonary Disease
por: Arian, Anahita, et al.
Publicado: (2018)

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Song, Wen, et al.
Publicado: (2021)

Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We?
por: Bridi, Guilherme das Posses, et al.
Publicado: (2023)

Neurophysiological Aspects and their relationship to clinical and functional impairment in patients with Chronic Obstructive Pulmonary Disease
por: de Miranda Rocco, Carolina Chiusoli, et al.
Publicado: (2011)

Nasal polyposis in cystic fibrosis: follow-up of children and adolescents for a 3-year period()
por: Weber, Silke Anna Theresa, et al.
Publicado: (2016)

Relationship of serum levels of interleukin 6, interleukin 8, and C-reactive protein with forced expiratory volume in first second in patients with mustard lung and chronic obstructive pulmonary diseases: systematic review and meta-analysis
por: Shahriary, Alireza, et al.
Publicado: (2017)

Discrepancy of C-Reactive Protein, Procalcitonin and Interleukin-6 at Hospitalization: Infection in Patients with Normal C-Reactive Protein, Procalcitonin and High Interleukin-6 Values
por: Lee, Eun-Hwa, et al.
Publicado: (2022)

Collagenofibrotic Glomerulopathy: Three Case Reports in Brazil
por: Ferreira, Renata DR, et al.
Publicado: (2009)

Serum levels of visfatin, sirtuin-1, and interleukin-6 in stable and acute exacerbation of chronic obstructive pulmonary disease
por: Ghobadi, Hassan, et al.
Publicado: (2021)

Pretenders and Contenders: Inflammation, C‐Reactive Protein, and Interleukin‐6
por: Daniels, Lori B.
Publicado: (2017)

Health Promotion in Obstructive Sleep Apnea Syndrome
por: Corrêa, Camila de Castro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ri2q731r08djvuifm11nrphll0